MOONLAKE IMMUNOTHERAPEUTICS Stock Redeemed or Called During Period, Value
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Stock Redeemed or Called During Period, Value of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2026-02-25
- MOONLAKE IMMUNOTHERAPEUTICS stock redeemed or called during period, value for the quarter ending 2024-03-31 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS stock redeemed or called during period, value for the quarter ending 2021-06-30 was $152.33K.
- MOONLAKE IMMUNOTHERAPEUTICS stock redeemed or called during period, value for the quarter ending 2021-03-31 was $76.29K.
- MOONLAKE IMMUNOTHERAPEUTICS stock redeemed or called during period, value for fiscal 2024 was $0.00.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 5 month | Stock Redeemed or Called During Period, Value 6 month | Stock Redeemed or Called During Period, Value 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-11-05 | |||
| 2021-06-30 | $152.33K 10-Q · filed 2021-08-16 | $228.62K derived: sum of 2 quarters · filed 2021-08-16 | ||
| 2021-03-31 | $76.29K 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $6.75M 10-K/A · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |